226 Ergebnisse für "immunotherapies"

Development of a novel class of interleukin-2 immunotherapies for m...

... immunotherapies for metastatic cancer. Swiss Medical Weekly, 149:w14697. Copy Abstract Tumour immunotherapy, and ... Development of a novel class of interleukin-2 immunotherapies for metastatic cancer - Zurich Open ... Development of a novel class of interleukin-2 immunotherapies for metastatic cancer - Zurich Open ... Development of a novel class of interleukin-2 immunotherapies for metastatic cancer - Zurich Open ...

Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular imm...

... Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular immunotherapies Meet Dr Rodrigo ... Vazquez-Lombardi working on engineered cellular immunotherapies The Peruvian-Australian researcher ... Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular immunotherapies – Department of ... Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular immunotherapies – Department of ... Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular immunotherapies – Department of ...

Emerging immunotargets and immunotherapies in prostate cancer - Zur...

... Emerging immunotargets and immunotherapies in prostate cancer - Zurich Open Repository and Archive ... Emerging immunotargets and immunotherapies in prostate cancer - Zurich Open Repository and Archive ... Emerging immunotargets and immunotherapies in prostate cancer - Zurich Open Repository and Archive ...

Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular imm...

... Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular immunotherapies Meet Dr Rodrigo ... Vazquez-Lombardi working on engineered cellular immunotherapies The Peruvian-​Australian researcher ... Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular immunotherapies – Laboratory for ... Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular immunotherapies – Laboratory for ... Meet Dr Rodrigo Vazquez-Lombardi working on engineered cellular immunotherapies – Laboratory for ...

A path forward to improving the specificity of immunotherapies - Re...

... A path forward to improving the specificity of immunotherapies - Research Collection ... A path forward to improving the specificity of immunotherapies - Research Collection Header Upper ... A path forward to improving the specificity of immunotherapies - Research Collection ...

04 – Laboratory for Systems and Synthetic Immunology | ETH Zurich

... (PHRT) Postdoctoral Fellowship to support his work on engineered cellular immunotherapies in Professor ... cellular immunotherapies The Peruvian-​Australian researcher recently took up a Personalized Health and ... immunotherapies in Professor Sai Reddy's Laboratory. 03.04.2018 by Cédric Weber Additional Information Search news ...

Immunity, Hypoxia and Metabolism - the ménage à trois of cancer: im...

... restrictive TME and as important players in the anti-tumor immune response; iii) to define how immunotherapies ... and metabolites within the TME impinge on the success of immunotherapies. By analyzing preclinical and ... restrictive TME and as important players in the anti-tumor immune response; iii) to define how immunotherapies ... and metabolites within the TME impinge on the success of immunotherapies. By analyzing preclinical and ...

Microsoft PowerPoint - 15-1 _15-1_Franz-Josef Obermair [Compatibili...

... products in the field of  Cancer immunotherapies  Autoimmune diseases  Infectious diseases The vision is ... products in the field of  Cancer immunotherapies  Autoimmune diseases  Infectious diseases The vision is ...

http://cdr-life.com/wp-content/uploads/2018/05/PR_20180523.pdf

... of novel immunotherapies in patient biopsies ZURICH, Switzerland, May 23, 2018 – CDR-Life inc. has ... technology. The collaboration will use synergies between the modular multispecific immunotherapies from CDR ... of novel immunotherapies in patient biopsies ZURICH, Switzerland, May 23, 2018 – CDR-Life inc. has ... technology. The collaboration will use synergies between the modular multispecific immunotherapies from CDR ...

https://www.virometix.com/wp-content/uploads/2022/03/Oncometix_Job-...

... , Switzerland, towards the evaluation of nanoparticle-based cancer vaccines and immunotherapies ... vaccine targets and immunotherapies • Mammalian cell culture and experience with cancer cell lines ... , Switzerland, towards the evaluation of nanoparticle-based cancer vaccines and immunotherapies ... vaccine targets and immunotherapies • Mammalian cell culture and experience with cancer cell lines ...

Mehr Ergebnisse

Nach oben